Floatz logo

PROSTAGLANDIN E1

Stroke

The First Hospital of Jilin UniversitySmall moleculePhase 4 / ApprovedActive
B
56/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
65/ 100

Competitive context

132 Active assets in the Stroke cohort.

Asset / SponsorPhaseRating
INCOBOTULINUMTOXINA
Parc de Salut Mar
Phase 4BBB
Aggrenox
Boehringer Ingelheim
Phase 4BBB
ATENOLOL
Northern California Institute of Research and Education
Phase 4BBB
Dextromethorphan
University of Florida
Phase 4BBB
Rivaroxaban
China National Center for Cardiovascular Diseases
Phase 4BBB

View all 50 →

Same molecule, other indications

PROSTAGLANDIN E1 is also rated in:

erectile dysfunctionDormant
B
Indicative ·
60 / 100
View asset →
obstetric disorderDormant
B
Indicative ·
57 / 100
View asset →
prostate cancerDormant
CCC
Indicative ·
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →